RFL · Rafael Holdings, Inc.
$1.99
-0.11 (-5.24%)
At close · Jul 29
Market Cap
$109.20M
Shares
52.00M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| William Conkling | CEO | $592,912 |
| John Goldberg | Former Chief Medical Officer and Named Executive Officer | $533,753 |
| David Polinsky | CFO | $527,353 |
| Howard S. Jonas | CEO | $294,000 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| William Conkling | CEO | $859,303 |
| John Goldberg | Former Chief Medical Officer and Named Executive Officer | $758,058 |
| Howard S. Jonas | Chairman | $540,333 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| William Conkling | CEO | $751,949 |
| David Polinsky | CFO | $646,800 |
| Patrick Fabbio | CFO | $533,278 |
| Howard S. Jonas | Chairman | $40,000 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ameet Mallik | CEO | $5,450,000 |
| Patrick Fabbio | CFO | $4,586,451 |
| William Conkling | CEO | $3,295,988 |
| Mary Margaret Huizinga | Former Chief Medical Officer and Former Head of Research and Development and Named Executive Officer | $2,823,336 |
| Howard S. Jonas | Chairman | $1,073,750 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Ameet Mallik | CEO | $47,332,791 |
| William Conkling | CEO | $3,212,259 |
| David Polinsky | CFO | $405,150 |
| Howard S. Jonas | Chairman | $250,000 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David Polinsky | CFO | $388,150 |
| Menachem Ash | General Counsel | $350,078 |
| Howard S. Jonas | CEO | $250,000 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Menachem Ash | General Counsel | $1,489,885 |
| David Polinsky | CFO | $255,500 |
| Howard S. Jonas | CEO | $250,000 |